Pediatric Cancers
Each year, more than 15,000 children in the U.S. are diagnosed with cancer. At City of Hope, your child will be cared for by a dedicated team of world-class professionals specially trained in pediatric cancers.
Pediatric oncologists, hematologists, surgeons, radiation therapists, pathologists and others work together to develop targeted and effective treatment plans, while professionals in psychology, social work, physical therapy, occupational therapy, recreational therapy, music therapy and school reintegration provide support to patients and their families.
City of Hope specializes in the treatment of childhood cancers and blood disorders. With the ever-increasing number of childhood cancer survivors, we also emphasize long-term survivorship, providing continued surveillance to monitor and proactively address the long-term effects of childhood cancer.
At City of Hope, we take the advances made by researchers in our laboratories and turn them into lifesaving therapies as quickly as possible. Many of these new therapies are not always available elsewhere.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your loved ones take each step during and after pediatric cancer treatment.
City of Hope is a member of the Children's Oncology Group, which maintains rigorous staffing, services and facilities standards for treating children's cancer. COG institutions treat 90% of all pediatric cancer cases in the U.S.
Through COG, City of Hope has access to the nation's largest group of clinical trials for pediatric and adolescent cancers.
We specialize in the treatment of cancers and blood disorders that occur most often in children, adolescents and young adults, including:
- Leukemia and lymphoma
- Bone, joint and soft tissue tumors
- Brain tumors
- Neuroblastoma
- Hemophilia, sickle cell disease and aplastic anemia, and other blood disorders
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
